Tremfya Leads TV Pharma Ads in September and Q3
Johnson & Johnson's Tremfya retained its top spot for TV pharma brand ad impressions in September, with a 5.02% impressions share of voice (SOV) and 3.1 billion impressions, following an ad spend of $32.8 million.
The fall sports season, particularly college football and Spanish language TV, drove the majority of TV pharma ad impressions. Tremfya's ads were mostly seen on Univision's ¡Despierta América!
- Vicks took the runner-up title with a 4.71% impressions SOV and 2.9 billion impressions, primarily through CBS and GMA 3: What You Need to Know, after investing $10.3 million in TV ad spend.
- AbbVie's Skyrizi was knocked to third place.
The psoriasis/ulcerative colitis drug scored most of its impressions from Univision’s ¡Despierta América!
Author's summary: Tremfya leads TV pharma ads in September.
More News
- Caribbean Equality Project celebrates a decade of resistance and belonging
- Military archbishop: Army’s cancellation of religious support contracts unfairly harms Catholics - OSV News
- Traditional ecological knowledge is under threat in the Vietnamese Mekong Delta
- Withdraw Presidential Pardon For Convicted Politicians - SERAP Calls On Tinubu - Gistmania
- NADRA Introduces New Digital ID and Data Exchange Regulations for 2025 - PhoneWorld
- 12 Best Custom PC Building Websites